Marek Mirowski

7PUBLICATIONS
16CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cheminformatics and quantitative structure-activity relationshipsNatural products and bioactive compounds
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 13, 2026
Advances in the Treatment of Ulcerative Colitis-From Conventional Therapies to Targeted Biologics and Small Molecules.

Aleksandra Wilk, Mateusz Pawłowski, Ewa Balcerczak

|Jan 30, 2026
In Silico and Wet Analysis of BAX Gene G-248A Polymorphism and mRNA Expression in Peptic Ulcer Disease and Gastric Cancer.

Marta Żebrowska-Nawrocka, Rafał Świechowski, Dagmara Szmajda-Krygier

|Sep 27, 2025
Monoclonal Antibodies: Historical Perspective and Current Trends in Biological Drug Development.

Barbara Madej, Filip Tomaszewski, Dagmara Szmajda-Krygier

|May 25, 2024
Historical Perspective and Current Trends in Anticancer Drug Development.

Katarzyna Gach-Janczak, Joanna Drogosz-Stachowicz, Anna Janecka

|Apr 13, 2023
Anticancer Properties of 3-Dietoxyphosphorylfuroquinoline-4,9-dione.

Joanna Drogosz-Stachowicz, Katarzyna Gach-Janczak, Marek Mirowski

|May 26, 2021
Importance of Altered Gene Expression of Metalloproteinases 2, 9, and 16 in Acute Myeloid Leukemia: Preliminary Study.

Jacek Pietrzak, Marek Mirowski, Rafał Świechowski

Pageof 2